These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 29696374)
1. BAALC and ERG expression levels at diagnosis have no prognosis impact on acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. Zhang J; Shi J; Zhang G; Zhang X; Yang X; Yang S; Wang J; Ke X; Fu L Ann Hematol; 2018 Aug; 97(8):1391-1397. PubMed ID: 29696374 [TBL] [Abstract][Full Text] [Related]
2. Over expression of brain and acute leukemia, cytoplasmic and ETS-related gene is associated with poor outcome in acute myeloid leukemia. Hasan SK; Patkar NV; Rajamanickam D; Gokarn A; Lucena-Araujo AR; Tembhare P; Bagal B; Kadam Amare P; Jain H; Gujral S; Sengar M; Subramanian PG; Khattry N Hematol Oncol; 2020 Dec; 38(5):808-816. PubMed ID: 32893896 [TBL] [Abstract][Full Text] [Related]
3. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study. Marcucci G; Maharry K; Whitman SP; Vukosavljevic T; Paschka P; Langer C; Mrózek K; Baldus CD; Carroll AJ; Powell BL; Kolitz JE; Larson RA; Bloomfield CD; J Clin Oncol; 2007 Aug; 25(22):3337-43. PubMed ID: 17577018 [TBL] [Abstract][Full Text] [Related]
4. Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML. Jentzsch M; Bill M; Grimm J; Brauer D; Backhaus D; Goldmann K; Schulz J; Niederwieser D; Platzbecker U; Schwind S Ann Hematol; 2020 Oct; 99(10):2417-2427. PubMed ID: 32862286 [TBL] [Abstract][Full Text] [Related]
5. ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays. Metzeler KH; Dufour A; Benthaus T; Hummel M; Sauerland MC; Heinecke A; Berdel WE; Büchner T; Wörmann B; Mansmann U; Braess J; Spiekermann K; Hiddemann W; Buske C; Bohlander SK J Clin Oncol; 2009 Oct; 27(30):5031-8. PubMed ID: 19752345 [TBL] [Abstract][Full Text] [Related]
6. BAALC and WT1 expressions from diagnosis to hematopoietic stem cell transplantation: consecutive monitoring in adult patients with core-binding-factor-positive AML. Yoon JH; Kim HJ; Shin SH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Lim JH Eur J Haematol; 2013 Aug; 91(2):112-21. PubMed ID: 23672350 [TBL] [Abstract][Full Text] [Related]
7. High Cheng Z; Dai Y; Pang Y; Jiao Y; Liu Y; Cui L; Qian T; Quan L; Cui W; Pan Y; Ye X; Shi J; Fu L Cancer Biol Ther; 2019; 20(10):1314-1318. PubMed ID: 31306053 [TBL] [Abstract][Full Text] [Related]
8. Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1. Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Wu S; Zhang L; Zhang Y; Wang X; Wang L; Ma D; Qin T; Hu N; Zhang Y; Hu K; Zhang Q; Shi J; Fu L Cell Physiol Biochem; 2018; 47(5):1853-1861. PubMed ID: 29961066 [TBL] [Abstract][Full Text] [Related]
9. Gene expression of BAALC, CDKN1B, ERG, and MN1 adds independent prognostic information to cytogenetics and molecular mutations in adult acute myeloid leukemia. Haferlach C; Kern W; Schindela S; Kohlmann A; Alpermann T; Schnittger S; Haferlach T Genes Chromosomes Cancer; 2012 Mar; 51(3):257-65. PubMed ID: 22072540 [TBL] [Abstract][Full Text] [Related]
10. Implication of higher BAALC expression in combination with other gene mutations in adult cytogenetically normal acute myeloid leukemia. Yoon JH; Kim HJ; Shin SH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Lim JH Leuk Lymphoma; 2014 Jan; 55(1):110-20. PubMed ID: 23647058 [TBL] [Abstract][Full Text] [Related]
11. Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations. Chou SC; Tang JL; Hou HA; Chou WC; Hu FC; Chen CY; Yao M; Ko BS; Huang SY; Tsay W; Chen YC; Tien HF Leuk Res; 2014 Nov; 38(11):1278-84. PubMed ID: 25260824 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype. El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678 [TBL] [Abstract][Full Text] [Related]
13. BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Schwind S; Marcucci G; Maharry K; Radmacher MD; Mrózek K; Holland KB; Margeson D; Becker H; Whitman SP; Wu YZ; Metzeler KH; Powell BL; Kolitz JE; Carter TH; Moore JO; Baer MR; Carroll AJ; Caligiuri MA; Larson RA; Bloomfield CD Blood; 2010 Dec; 116(25):5660-9. PubMed ID: 20841507 [TBL] [Abstract][Full Text] [Related]
14. Mild chronic graft-versus-host disease may alleviate poor prognosis associated with FLT3 internal tandem duplication for adult acute myeloid leukemia following allogeneic stem cell transplantation with myeloablative conditioning in first complete remission: a retrospective study. Nasilowska-Adamska B; Czyz A; Markiewicz M; Rzepecki P; Piatkowska-Jakubas B; Paluszewska M; Dzierzak-Mietla M; Solarska I; Borg K; Prochorec-Sobieszek M; Szydlo R; Lewandowski K; Skotnicki A; Jedrzejczak WW; Kyrcz-Krzemien S; Komarnicki M; Warzocha K Eur J Haematol; 2016 Mar; 96(3):236-44. PubMed ID: 25912052 [TBL] [Abstract][Full Text] [Related]
15. Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia. Staffas A; Kanduri M; Hovland R; Rosenquist R; Ommen HB; Abrahamsson J; Forestier E; Jahnukainen K; Jónsson ÓG; Zeller B; Palle J; Lönnerholm G; Hasle H; Palmqvist L; Ehrencrona H; Blood; 2011 Nov; 118(22):5905-13. PubMed ID: 21967978 [TBL] [Abstract][Full Text] [Related]
16. Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. Langer C; Marcucci G; Holland KB; Radmacher MD; Maharry K; Paschka P; Whitman SP; Mrózek K; Baldus CD; Vij R; Powell BL; Carroll AJ; Kolitz JE; Caligiuri MA; Larson RA; Bloomfield CD J Clin Oncol; 2009 Jul; 27(19):3198-204. PubMed ID: 19451432 [TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations. Xu Y; Sun Y; Shen H; Ding L; Yang Z; Qiu H; Sun A; Chen S; Wu D Am J Hematol; 2015 Nov; 90(11):992-7. PubMed ID: 26223865 [TBL] [Abstract][Full Text] [Related]
18. Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041 [TBL] [Abstract][Full Text] [Related]
19. Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome. Baldus CD; Martus P; Burmeister T; Schwartz S; Gökbuget N; Bloomfield CD; Hoelzer D; Thiel E; Hofmann WK J Clin Oncol; 2007 Aug; 25(24):3739-45. PubMed ID: 17646667 [TBL] [Abstract][Full Text] [Related]
20. BAALC and ERG expression in acute myeloid leukemia with normal karyotype: impact on prognosis. Eid MA; Attia M; Abdou S; El-Shazly SF; Elahwal L; Farrag W; Mahmoud L Int J Lab Hematol; 2010 Apr; 32(2):197-205. PubMed ID: 19555438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]